Metaclipse Therapeutics Corporation
Biotechnology, 3175 Presidential Dr, Atlanta, Georgia, 30340, United States, 11-50 Employees
Phone Number: 14*********
Who is METACLIPSE THERAPEUTICS CORPORATION
Metaclipse Therapeutics is a preclinical stage biotech company developing novel cancer therapies that are tailored to each patient and their specific tumor. The Companys first personalize...
Read More
-
Headquarters: 3175 Presidential Dr, Atlanta, Georgia, 30340, United States
-
Date Founded: 2012
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO:
Michael Coleman
Email
Phone
Industry: Biotechnology
SIC Code: 2836
Does something look wrong? Fix it. | View contact records from METACLIPSE THERAPEUTICS CORPORATION
Metaclipse Therapeutics Corporation Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Metaclipse Therapeutics Corporation
Answer: Metaclipse Therapeutics Corporation's headquarters are located at 3175 Presidential Dr, Atlanta, Georgia, 30340, United States
Answer: Metaclipse Therapeutics Corporation's phone number is 14*********
Answer: Metaclipse Therapeutics Corporation's official website is https://metaclipsetherapeutics.com
Answer: Metaclipse Therapeutics Corporation's revenue is $1 Million to $5 Million
Answer: Metaclipse Therapeutics Corporation's SIC: 2836
Answer: Metaclipse Therapeutics Corporation has 11-50 employees
Answer: Metaclipse Therapeutics Corporation is in Biotechnology
Answer: Metaclipse Therapeutics Corporation contact info: Phone number: 14********* Website: https://metaclipsetherapeutics.com
Answer: Metaclipse Therapeutics is a preclinical stage biotech company developing novel cancer therapies that are tailored to each patient and their specific tumor. The Companys first personalized cancer therapy is for triple negative metastatic breast cancer. Metaclipse intends to commercialize its products through licensing agreements with major pharmaceutical companies after establishing their safety and effectiveness in early clinical trials by year-end 2019.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month